Publications by authors named "C B Zamboni"
Alleviating radiologists' childcare woes: A roadmap for the 21st century.
Curr Probl Diagn Radiol
November 2024
This manuscript illuminates the need for childcare support for trainees and faculty in the field of radiology, highlighting the essential need for access, affordability, and high-quality childcare services. For over four decades, women radiologists have voiced the challenges of meeting both childcare and professional responsibilities. The COVID-19 pandemic highlighted systemic inadequacies in the childcare infrastructure, exacerbating the challenges of this long-standing balancing act.
View Article and Find Full Text PDFBackground And Purpose: To evaluate the radiomics-based model performance for differentiation between glioblastoma (GB) and brain metastases (BM) using magnetization prepared rapid gradient echo (MPRAGE) and volumetric interpolated breath-hold examination (VIBE) T1-contrast enhanced sequences.
Materials And Methods: T1-CE MPRAGE and VIBE sequences acquired in 108 patients (31 GBs and 77 BM) during the same MRI session were retrospectively evaluated. Post standardized image pre-processing and segmentation, radiomics features were extracted from necrotic and enhancing tumor components.
Myeloid sarcoma (MS) is a solid tumor of granulocytic origin with extramedullary localization. This tumor is rare in humans and animals. The diagnostic approach is heterogeneous, and the definitive diagnosis may be difficult to achieve.
View Article and Find Full Text PDFArticle Synopsis
- High levels of survivin expression in canine perivascular wall tumors (cPWTs) are linked to worse clinical outcomes, with a significant increase in death risk correlating to nuclear survivin levels.
- The study involved analyzing 41 cPWTs through immunohistochemistry, revealing widespread expression of survivin and β-catenin, though only nuclear survivin showed a strong prognostic significance.
- Other factors like tumor size and mitotic count also emerged as potential prognostic indicators, suggesting that survivin and β-catenin might be valuable targets for future therapies in treating these tumors.
Objective: To evaluate whether patients older than 60 years admitted for fracture treatment had a history of previous fracture, a diagnosis of osteoporosis, or were under treatment for bone fragility.
Methods: Retrospective study including 100 patients older than 60 years with fracture. Fracture location, bone densitometry within the past two years, previous diagnosis and osteoporosis treatment, and previous fracture within the past five years were assessed.